Informa

“I’m glad I’m at Biopharma Conclave, I felt that the leadership panel was quite good, with a mix of industry leaders as well as Government representation. The conference seems fairly well lined up with very relevant topics. I’ve been part of the industry for 20 years, maybe more than that and I’m glad that in this conference I’m able to catch up with old friends from the biopharma industry and understand essentially what those guys are doing. I see a lot of promise for networking down the line in the different networking sessions that have been planned and I’m definitely planning to all the excitement is going on! I think the content is very well lined up, I think its not just the lining up of the content but I think the order in which the content is being really brought together. I would certainly recommend this to the new entrance level in the industry to enable them to get this exposure. If I had to describe the event in few words, I’d say Informative, exciting and where old friends can come together to chit chat about their professional domains.”

Prof. Samir Kulkarni
Head - Department of Biological Sciences and Biotechnology, Institute of Chemical Technology

“This is the 7th Edition of Biopharma Conclave and I’ve been attending since the 1st Edition of the conference, this year Biopharma event has been the biggest one I’ve ever seen! And response from the participants is overwhelming and I could see that the audience space was fully filled, and people were standing back. There are lot of eminent speakers from all over the world have come. People travelled from Bangalore, Mumbai and different cities of India and this is really Awesome. The Agenda was very well crafted starting from the leadership panel, which discussed global uncertainties, global macroeconomics scenarios, and how the Biopharma industry is going to sustain over a period of time. I would encourage all the participants to interact with them and collaborate with them so that in future with come up with our indigenous new biological entities and be a global superpower in the field of biopharma. This conference is amazing!”

Dr. Tathagata Dutta
President, Jodas Expoim

“This event was helpful in getting myself to acclimatize the biopharma activities that are happening and the findings that are there. This is a great networking event, I happen to learn more about the different companies, technologies, and the different aspects of the biopharma industry and I think this event are every much needed for advancement of the biopharma field. The event went very well in regard to the content, it had touched more amount of activates that had happened in the biopharma world, in terms of the ADCs, Mono-clonal anti bodies, and the BCAs and other things. The panel discussion were also good, good speakers how also brought the national & International perspective in Biopharma industry. If I had to describe the event in one word Id say this is a complete event!”

Dr. Venkata Sasidhar Manda
Chief Scientific Officer, Apollo Hospitals Educational and Research Foundation

“It has been a pleasure and a pleasant surprise to be here, looking at the attendance and the magnificent sessions that had been organized, it was really heartening to see the good discussions around biopharma, which is what we promote in India. It is very heartening to see so much interest in the ecosystem, and we are happy to be a part of this gathering. It provides an excellent opportunity to network with players in the ecosystem, and the other thing is you get so many insights which you cannot get from any publication or any other journal, you get it firsthand from the experienced minds. It is very positive and important outcome. The content is well curated and the people that participated have come well prepared and well advised, even in my case we had a pre-meeting so we could create good content for the audience. So in that case it is very well organized and very well thought out. Wishing you the very best. It is very organized, well-timed event.

Dr. Raj Shirumalla
National Mission Director Biotechnology Industry Research Assistance Council BIRAC, Govt. of India

“I also look forward to attending such events in India, today I focused on Cell & Gene Therapy, tomorrow I’ll focus on Biopharma and supply chain. This Conclave have brought like-minded people and that’s one thing that we greatly benefit from. We have got good amount of talent here and the other thing is vendors – people that provide services for our active product development, whatever is happening in the industry. And that just helps us keep a touch with whatever is happening in the industry in all senses and its good for the ecosystem and that’s what is benefiting us also. All this conference is happening at the same level of what is organised in Europe & US. So, it is at the same standard, so it is meeting the expectations globally now not just India. The networking is great, we have had a good amount of Attendance on both side of the companies, the scientific side & the non-scientific side. I have taken a lot of insights from the sessions – the panel sessions, Fireside conversations, and the planery lectures. So, I think it is at pawers as I said. To describe the event in one word, its seamless”

Dr. Tulip Nuwal
Head - Cell & Gene Therapy Operations, Intas Pharmaceuticals

“The event is good, we can see good delegates to the event to attend, and the sessions were good. Lot of good footfall in our stall as well. The event has help us meet our target audience, we meet few of them displaying our products first hand, it was a hands-on experience for the customer as well. So far so good, we had good networking, and we expect more, it was a good experience. Those who came to our stall, those participants, those delegates that we wanted came to us, the communication that we wanted to happen has happened. The one-word I’d describe the event in is well orchestrated and I would like to attend this event next year.”

Team Corning (Exhibitor)

“Overall experience was really good, so I could see a lot of key decision makers attend the event, so it is quite positive. Networking opportunity is quite good, so I could see a lot of small incubators, startups were getting into the CAR-T space, so that was quite good so quite motivating. This platform is good for both Biologics and Cell & Gene therapy, so Lonza is into biologics, specifically the media. We sell the media, the saline platforms & for the CGT that is CAR-T space we have a lot of solutions for the instrumentations like cocoon & media of course so it is a mix of both. It is a very strong networking arena”

Team Lonza (Exhibitor)

“Overall experience is 10 out of 10, it has been the event of the year for us in India. We are coming back every year and we are coming back for 2026. During this event I met multiple stakeholders in biological testing, in biosimilar space, in monoclonal antibody space, as well as stage 2 was fantastic on Cell & Gene Therapy. You have a great set of speakers, you had a great panel discussing advances in Indian regulatory system and how to improve and reduce cost for the Indian population for cell therapy treatment. So, in relation to other events in comparison to Asia Pacific instead of India specifically as the market is quite big and has a lot of potential. I would say it is an event to be definitely present at, to have your presence as exhibitors as speaker. Compared to last year this year was much better, much more targeted audience, much more engagement with clients and if I were to describe in one word this years Biopharma Conclave, it was vibrant and full of opportunities, so everyone should try to be here in 2026”

Team Charles Rivers Laboratories (Exhibitor)

“So overall rating for Biopharma Conclave is 10 out of 10, the networking part is great. We had a good meeting with our existing customers & potential customers. It was an overall good experience, properly organised, good networking time. And we are looking forward to this for next year too. So, basically if you see whatever product line if are pitching in market is for Cell & Gene Therapy and Biosimilars and that is the future of Therapy, Cell therapy & Gene therapy. A lot of people in India have started research on cell therapy and they are doing very good research, and we are their supplier. So, it is good for us platform, we meet them we understand what future research they do. And what are their challenges and how we can support them. Attending this event was superb, great because over a period we have attended few of other conference also, but this experience is very good.”

Team Acro Biosystem (Exhibitor)

“I think it is very good, I have been associated with Informa Markets for last couple of years as an advisor, working with you to make this conference successful and I think things have been improving and we are having good speakers, and we are having good topics also to cover in this aspect. I think beside the individual talks, panel discussions involve discussing a challenge from multiple angles, what are the challenges & how can things be addressed. And I think the best take away for all the industry people. Both the leaders as well as the junior people as well as the people who are sitting in the audience and listening all this. It is an excellent event.”

Dr. Ranjan Chakrabarti
Biopharma Professional

“It is a very friendly environment. It’s nice to see some colleagues & ex colleagues and friends that we have met in other conferences, so very nice networking & environment. The agenda was very informative; I saw even on the 2nd day whole hall being full that means that the content is very helpful for the industry. To describe the event in one word, it was very insightful”

Dr. Parthasarathy Sampathkumar
Head - Biocon Group Centre of Excellence, Biocon Group

“It is a very friendly environment. It’s nice to see some colleagues & ex colleagues and friends that we have met in other conferences, so very nice networking & environment. The agenda was very informative; I saw even on the 2nd day whole hall being full that means that the content is very helpful for the industry. To describe the event in one word, it was very insightful”

Dr. Shubhadeep Sinha
Senior Vice President - CD & MA, Hetero

“At this Biopharma Conclave, its been very enriching and enlightening experience and go to hear some great panels, great talks. Very enriching and very forward looking & looking forward to the future of Biopharma in India. The topics and agenda have been very well rounded. From discovering to novel technologies like ours all the way to manufacturing and regulation, Academia – Industry collaboration, I think it has captured the length and breadth of the topics for sure. I think there’s definitely a need for having enough knowledge to the field both I think we have discussed it till length, the academic world and the industry world stay very separated and far apart and events like these do help them to bring things together and align the thought process and the major outcomes. One word to describe the event is Enlightening.”

Dr. Aridni Shah
Co-Founder & CEO, immunitoAI

“The experience at Biopharma Conclave have been excellent, we have brought Professionals from industry together, putting them in the same room and making them discuss science and technology and this has been very enlightening, so really enjoyed the event and going forward more force to this event. Biopharma Conclave is bringing people together, the right leaders, the right scientists. This is the need of the hour for the Biopharma Industry today. Putting the people in the same room, going through presentations and when interacting with each other to find the collaborative opportunities. The tremendous step that is required in today’s industry. Informa Markets is doing a great service to the industry conducting this event. So, content has covered science, technologies, directionality & the mindset. Going forward how to integrate all of them in a crisper way, it continues to be important so selecting the right presenters, speakers and having the write panel and having the write channels in this like you have panel discussion, you have fireside chats and having the speaker presentation, I think continues to be a involving game and they have to be on top of the industry, what is going on in the industry. One word to describe the conference would be warm, enlightening and very interactive.

Abhishek Mathur
Global Pharma Leader, (ex- Amgen, Regeneron)

“Interactions have been very good, exchange of information in terms of biosimilars, vaccines or even the cell & gene therapy is very new in the market. There is a lot of learning from both ends. The footfall for this event in the last two days have been phenomenal and more than expected.”

Vishal Jaiman
Director – Business Development (India), Marken

“Biopharma Conclave was very good, I think there are a lot more players in the market with lot more presenting this year.It’s an interesting mix of all the topics they have put together as the Biopharma industry is moving further into commercialization. This is a good platform for a lot of us to connect and present our views.”

Gopal Rao
GM- Global BD and Licensing, Lupin Limited (Biotech Division)

“So far it has been a wonderful experience and I was able to interact as well as meet many key personalities from India and abroad. We have expertise industry research in Biosimilars, Biologics, Vaccines and Gene therapy hence it has been a wonderful experience to learn a lot of advance techniques and development happening in this space.”

Ramgopal Rao
Academic Manger, Biocon Academy

“My experience at the Biopharma Conclave was great. It was good to hear from so many experts in the field of biopharma. The quality of the speakers is top notch, and it was great to hear from regulators and industry experts.”

Dr. Sarah McMullen
Country Director, US FDA

“This is the first day but there were so many interesting topics withvery interesting speakers. It was a networking event and informative session with lots of people.”

Yaron R. Silberberg
PHD. Chief Scientist, Cellist Solution Center

“I was very glad to know that there were ample safety protocols followed whilst hosting a show post Covid. There was also a self-declaration form which each of the participants had to sign. There was a thermal screening at the entrance. In terms of the discussion the dignities who came there were all very well recognized and knowledgeable. It was great to learn from each other and a great platform as well.”

Divya Bijlwan
Senior Vice President- Business development, Aurobindo Pharma Ltd.

“It’s a very nice gathering and we have people come here from various streams that is Vaccines, Biosimilars and Gene therapy.”

Alston Fernandes
Head Technical, JNC Corporation